GSK Bets Big on Cancer Innovation With $10.6 Billion Nuvalent Acquisition
A major acquisition is reshaping the biotechnology landscape after pharmaceutical giant GSK agreed…
A major acquisition is reshaping the biotechnology landscape after pharmaceutical giant GSK agreed…